DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Nordette (Levonorgestrel / Ethinyl Estradiol) - Published Studies

 
 



Nordette Related Published Studies

Well-designed clinical trials related to Nordette (Levonorgestrel / Estradiol)

Effect of ticagrelor on the pharmacokinetics of ethinyl oestradiol and levonorgestrel in healthy volunteers. [2011.08]

Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables. [2006.07]

Effect of two oral contraceptives with different ethinyl estradiol and levonorgestrel concentrations on the urinary excretion of biochemical vasoactive markers. [2001.12]

A prospective randomized study comparing the clinical effects of a norethisterone and a levonorgestrel containing low dose oestrogen oral contraceptive pills. [1993.02]

A clinical comparison of two triphasic oral contraceptives with levonorgestrel or norethindrone: a prospective, randomized, single-blind study. [1993.01]

A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel. [1992.06]

Pharmacokinetic comparison of two triphasic oral contraceptive formulations containing levonorgestrel and ethinylestradiol. [1990.01]

Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version. [1983.05]

Well-designed clinical trials possibly related to Nordette (Levonorgestrel / Estradiol)

Comparative biochemical studies on steroidogenic compounds in chickens. [2010.10]

Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOs patients. [2010.09]

Scheduled and unscheduled bleeding patterns with two combined hormonal contraceptives: application of new recommendations for standardization. [2009.08]

[The influence of sequential hormonal therapy on biochemical and cardiovascular indices in menopause] [2008]

Effect of oral contraceptive with and without associated estriol on ultrasound measurements of breast fibroadenoma: randomized clinical trial. [2007.09.06]

Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in adolescent females with anorexia nervosa: a double-blind, placebo-controlled study. [2006.12]

Oral contraceptives for dysmenorrhea in adolescent girls: a randomized trial. [2005.07]

Concomitant administration of lumiracoxib and a triphasic oral contraceptive does not affect contraceptive activity or pharmacokinetic profile. [2004.06]

A multicenter, randomized study of an extended cycle oral contraceptive. [2003.08]

Prospective evaluation of two stimulation protocols for low responders who were undergoing in vitro fertilization-embryo transfer. [2003.04]

Clinical assessment and quality of life of postmenopausal women treated with a new intermittent progestogen combination hormone replacement therapy: a placebo-controlled study. [2003.01]

Levetiracetam does not alter the pharmacokinetics of an oral contraceptive in healthy women. [2002.07]

Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial. [2001.11]

A double-blind comparative study of the effects of a 23-day oral contraceptive regimen with 20 microg ethinyl estradiol and 75 microg gestodene and a 21-day regimen with 30 microg ethinyl estradiol and 75 microg gestodene on hemostatic variables, lipids, and carbohydrate metabolism. [2001.10]

Comparison of a novel norgestimate/ethinyl estradiol oral contraceptive (Ortho Tri-Cyclen Lo) with the oral contraceptive Loestrin Fe 1/20. [2001.06]

Acne resolution rates: results of a single-blind, randomized, controlled, parallel phase III trial with EE/CMA (Belara) and EE/LNG (Microgynon). [2001]

A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives. [1998.08]

The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives. [1998.02]

Effect of Depo-Provera or Microgynon on the painful crises of sickle cell anemia patients. [1997.11]

A randomized cross-over study comparing pharmacodynamic and metabolic variables of a new combiphasic and a well-established triphasic oral contraceptive. [1997.09]

Risk for ovulation in women taking a low-dose oral contraceptive (Microgynon) when receiving antibacterial treatment with a fluoroquinolone (ofloxacin). [1996.06]

Changes in androgens during treatment with four low-dose contraceptives. [1996.03]

The influence of Microgynon and Diane-35, two sub-fifty ovulation inhibitors, on voice function in women. [1995.12]

A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. [1994.09]

A comparative study of two low-dose combined oral contraceptives: results from a multicenter trial. [1993.08]

A multicenter comparative trial of triphasic and monophasic, low-dose combined oral contraceptives. [1993.06]

A randomized comparative open study of the effects of two oral contraceptives, Triphasil and Ortho 7/7/7, on lipid metabolism. [1993.02]

Effects of two low-dose oral contraceptives on erythrocyte superoxide dismutase, catalase and glutathione peroxidase activities. [1993]

Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial. [1992.11]

Long-term profile of a new progestin. [1992]

Effect of long-term triphasic oral contraceptive use on glucose tolerance and insulin secretion. [1991.07]

Effect of low-dose oral contraceptives on carbohydrate and lipid metabolism in women with recent gestational diabetes: results of a controlled, randomized, prospective study. [1990.12]

Cycle control on low-dose oral contraceptives: a comparative trial. [1990.09]

The effect of olestra on systemic levels of oral contraceptives. [1990.07]

Initial selection of oral contraceptives. [1990.05]

Comparative study on the effect of Diane and Microgynon 50 contraceptive on the haemostatic mechanisms in Chinese subjects. [1990.04]

A double-blind comparison of the efficacy and acceptability of Femodene and Microgynon-30. [1990.03]

A comparative study of three oral contraceptives in Ibadan: Norinyl 1/35, Lo-Ovral and Noriday 1/50. [1990.03]

Hemorheological effects of oral contraceptives. [1989.11]

Programmed oocyte retrieval: clinical and biological effects of oral contraceptives administered before in vitro fertilization. [1989.06]

Evaluation of the clinical performance of three triphasic oral contraceptives: a multicenter, randomized comparative trial. [1989.05]

Effects of three types of combined O.C. pills on blood coagulation, fibrinolysis and platelet function. [1989.04]

Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women. [1989.01]

The effect of triphasic and biphasic oral contraceptive preparations on HDL-cholesterol and LDL-cholesterol in young women. [1987.02]

The effect of different contraceptive treatments on the serum concentration of dehydroepiandrosterone sulfate. [1984.04]

Other research related to Nordette (Levonorgestrel / Estradiol)

A continuous regimen of levonorgestrel/ethinyl estradiol for contraception and elimination of menstruation. [2008.03]

Levonorgestrel as an emergency contraceptive drug. [2003.11]

Use of levonorgestrel implants versus oral contraceptives in adolescence: a case-control study. [1995.04]

Pharmacokinetics of ethinylestradiol and levonorgestrel after administration of two oral contraceptive preparations. [1992]

Other possibly related research studies

[Ectopia of cervix of the uterus and hormonal contraception] [2006.12]

Long-term safety of an extended-cycle oral contraceptive (Seasonale): a 2-year multicenter open-label extension trial. [2006.07]

Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol. [2006.03]

Contraceptive-related cerebral venous thrombosis with profuse vaginal bleed. [2005]

Peliosis hepatis revealed by biliary colic in a patient with oral contraceptive use. [2004.11]

Endometrial microstructure after long-term use of a 91-day extended-cycle oral contraceptive regimen. [2005.01]

[Experimental study on estrogenic function of triphasic contraceptive tablets] [2003.01]

Measuring performance during the menstrual cycle: a model using oral contraceptives. [2004.01]

Triphasic oral contraceptive treatment alters the behavior and neurobiology of female cynomolgus monkeys. [2004.01]

[Occurrence of bleeding in women using combined hormonal contraceptives (ethinylestradiol 35 micrograms/norgestimate 250 micrograms in relation to regularity of administration and cycle start day] [2003.03]

A comparison of therapy continuation rates of different hormone replacement agents: a 9-month retrospective, longitudinal analysis of pharmacy claims among new users. [2003.01]

Oral contraceptive-induced central retinal artery occlusion. [2002.08]

Renal papillary necrosis as first presentation of a Nigerian sickle cell patient. [2002.04]

Influence of low-dose oral contraception on peripheral blood lymphocyte subsets at particular phases of the hormonal cycle. [2002.07]

Contraceptive applications of estrogen. [2002.05]

Biphasic versus triphasic oral contraceptives for contraception. [2002.05]

Hormonal effects of Depo-Provera in cervical smears: a comparison with Triphasil and postmenopausal effects. [2002.04.25]

A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra). [2002.02]

The effects of an oral contraceptive containing ethinyloestradiol and norgestrel on CYP3A activity. [2002.01]

Rapid improvement of icterus and pruritus by the oral administration of colestimide in two cases of drug-induced hepatitis. [2001.11]

[Hormonal correction of the resident microflora of the vagina and uterus cervix in women with chronic cervicitis] [2001.07]

Rapid disappearance of hepatic adenoma after contraceptive withdrawal. [2001.09]

Testing the tyrosine/catecholamine hypothesis of oral contraceptive-induced psychological side-effects: a controlled study on triphasil. [2001]

Knowledge of emergency contraception among pharmacists and doctors in Durban, South Africa. [2001.03]

Oral contraceptives in the treatment of acne. [2001.02]

[Tri-Regol and its application in gynecological practice] [2000]

Ectopic gestation following emergency contraceptive pill administration. [2000.11]

[Changes in the concentration of individual proteins in women using current peroral contraceptives] [1999]

Oral contraceptives: a cause of hyperbilirubinemia in stem cell transplant patients. [1999.09]

[Current monophasic hormonal contraception] [1998]

Effects of menstrual cycle phase and oral contraceptive use on intermittent exercise. [1998.11]

Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis? [1998.09]

Ischemic colitis and acquired resistance to activated protein C in a woman using oral contraceptives. [1998.10]

Nutritional and psychological status of young women after a short-term use of a triphasic contraceptive steroid preparation. [1998]

[The use and effects of postcoital contraception] [1997.10.15]

The effects of monophasic and triphasic oral contraceptives on ovarian function and endometrial thickness. [1997.03]

Acceptability and discontinuation of Depo-Provera, IUCD and combined pill in Kenya. [1996.12]

Augmentation of low ovarian response to superovulation before in vitro fertilization following priming with contraceptive pills. [1996.12]

Emergency postcoital treatment: practical and ethical barriers to use. [1996.09]

Erythema multiforme. [1996.03]

Early effect of a low dose (30 micrograms) ethinyl estradiol-containing Triphasil on vitamin B6 status. A follow-up study on six menstrual cycles. [1996]

Clinical efficacy and safety of low-dose flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsutism. [1995.11]

Defects in carbohydrate metabolism in oral contraceptive users without apparent metabolic risk factors. [1994.11]

Postcoital contraception. Has its day come? [1994.11]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017